Ensuring the continuity and sustainability of anesthesia services during public health emergencies is a profound challenge for healthcare systems worldwide. This review explores key epidemiological considerations, underlying pathophysiological mechanisms, risk factors, clinical features, diagnostic strategies, management protocols, recent advances, and guideline recommendations relevant to anesthesia care during crises such as pandemics and natural disasters. Emphasis is placed on evidence-based strategies for resource optimization, infection prevention, workforce resilience, and the integration of novel technologies to maintain patient safety and service quality. The article synthesizes current scientific literature and expert consensus to provide practical insights for clinicians, hospital administrators, and policymakers tasked with safeguarding anesthesia services in times of acute healthcare demand.
Public health emergencies, including pandemics (e.g., COVID-19), natural disasters, and mass casualty incidents, substantially disrupt routine healthcare delivery. Anesthesia services, integral to surgical, critical care, and pain management, face unique operational and clinical challenges in these scenarios. These challenges stem from resource constraints, infection control imperatives, workforce shortages, and rapidly evolving clinical demands. Sustainable anesthesia practice during emergencies requires adaptive strategies grounded in scientific evidence, clear protocols, interdisciplinary collaboration, and robust infrastructure. This review provides an in-depth examination of the multifaceted approaches required to maintain essential anesthesia care without compromising safety, quality, or ethical standards.
Public health emergencies exert significant strain on perioperative services due to increased patient volume, altered casemix, and limited resources. For example, during the COVID-19 pandemic, elective surgeries were suspended globally, resulting in an estimated 28 million cancelled operations in 2020 alone. Emergency and trauma procedures predominated, often under challenging circumstances. Epidemiological data indicate heightened perioperative risk for patients with infectious diseases and increased occupational exposure for anesthesia providers. The burden extends to developing regions, where baseline anesthesia workforce and infrastructure deficits exacerbate the impact of emergencies, highlighting global health disparities and underscoring the need for sustainable solutions.
The pathophysiological considerations during public health emergencies vary with the triggering event. Infectious outbreaks may present with respiratory compromise, multi-organ dysfunction, or coagulopathy, all of which complicate anesthetic care. For instance, SARS-CoV-2 infection introduces risks of hypoxemia, acute respiratory distress syndrome, and cardiovascular instability under anesthesia. In disasters, trauma-induced hemorrhagic shock or toxic exposures demand tailored anesthetic techniques. Understanding these mechanisms is essential for perioperative planning, drug selection, airway management, and physiological monitoring, ensuring that anesthesia interventions align with the underlying disease processes and patient vulnerabilities.
Risk factors for adverse outcomes during anesthesia in emergencies include patient-specific variables (advanced age, comorbidities, immunosuppression), procedural urgency, and environmental factors such as inadequate personal protective equipment (PPE) or suboptimal operating room (OR) conditions. Provider risk is amplified by high viral load exposures, fatigue, and psychological stress. Systemic risk factors include disrupted supply chains, limited access to essential drugs, and insufficient critical care capacity. Identifying and mitigating these risks through triage protocols, preoperative screening, and workforce support are central to sustainable service delivery.
Patients requiring anesthesia during emergencies often present with atypical or advanced disease states. Infectious cases may show respiratory distress, fever, or altered mental status; trauma patients may arrive with hemodynamic instability or polytrauma. Clinical assessment is complicated by PPE barriers, time constraints, and infection control measures. Anesthesia providers must rapidly evaluate airway patency, ventilation, hemodynamics, and comorbidity profiles, integrating clinical judgment with protocol-driven care. Special consideration is needed for vulnerable populations, such as pediatric, obstetric, and immunocompromised patients, whose presentations and anesthetic requirements may differ from the general population.
Efficient diagnosis is critical in emergencies to prioritize cases and guide anesthesia planning. Preoperative screening for infectious diseases involves rapid antigen or molecular testing and imaging (e.g., chest radiography for COVID-19). Point-of-care ultrasound assists in trauma evaluation and vascular access. Laboratory tests assess coagulation, end-organ function, and inflammatory markers. Diagnostic workflows must balance thoroughness with speed, minimizing unnecessary exposure and delays. Multidisciplinary coordination with surgical, critical care, and infectious disease teams optimizes diagnostic accuracy and patient outcomes.
Treatment strategies focus on balancing patient safety with resource stewardship. Airway management protocols emphasize rapid-sequence induction, video laryngoscopy, and closed-circuit ventilation to reduce aerosolization risk. Regional anesthesia, where feasible, can minimize airway instrumentation and conserve ventilators. Drug shortages necessitate flexible anesthetic plans and alternative medication use. Enhanced recovery protocols, early mobilization, and streamlined discharge processes reduce inpatient burdens. Team-based care, including expanded roles for nurse anesthetists and anesthesia assistants, enhances service resilience. Ongoing staff training and mental health support are vital for sustaining workforce performance and well-being.
Recent advances enhancing sustainable anesthesia include telemedicine for preoperative assessment, remote monitoring, and virtual multidisciplinary meetings. Innovations in infection control such as negative-pressure ORs, advanced PPE, and ultraviolet sterilization improve provider safety. Rapid deployment of modular ORs and mobile anesthesia units extends capacity in resource-limited settings. Artificial intelligence and predictive analytics assist in case triage and resource allocation. Novel drug delivery systems and low-flow anesthesia techniques reduce waste and cost. These advances, though accelerated by recent emergencies, have enduring value for routine and crisis care alike.
International and national bodies (e.g., WHO, ASA, WFSA) recommend prioritizing urgent and emergent cases, maintaining stringent infection prevention protocols, and ensuring adequate PPE supply. Protocols advocate for minimizing personnel in high-risk areas, implementing designated COVID-19 ORs, and employing standardized airway management checklists. Workforce flexibility, cross-training, and psychological support are emphasized. Guidelines call for continuous review and adaptation based on emerging evidence and local epidemiology, with consistent communication and leadership engagement underpinning effective implementation.
The sustainability of anesthesia services during public health emergencies hinges on preparedness, adaptability, and evidence-based practice. A multifaceted approach combining epidemiological vigilance, mechanistic understanding, proactive risk mitigation, and adoption of technological advances enables healthcare systems to safeguard perioperative care in the face of adversity. Ongoing research, global collaboration, and investment in workforce and infrastructure are essential to ensure that anesthesia professionals can continue to deliver safe, effective, and equitable care during future crises.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation